iifl-logo

Glenmark Life Sciences Ltd Board Meeting

1,060
(2.53%)
Apr 2, 2025|12:00:00 AM

Glenmark Life CORPORATE ACTIONS

03/04/2024calendar-icon
03/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting23 Jan 202516 Jan 2025
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December 2024. We would wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine months ended December 31, 2024. (As Per BSE Announcement Dated on: 23/01/2025)
Board Meeting24 Oct 202417 Oct 2024
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended 30th September 2024. Please find attached herewith unaudited Finacial Results for the second quarter and half year ended 30th September 2024 (As per BSE Announcement Dated on 24/10/2024)
Board Meeting25 Jul 202418 Jul 2024
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the first quarter ended 30th June 2024. Please find attached unaudited financial result for First Quarter ended June 30, 2024 (As Per BSE Announcement Dated on: 25/07/2024)
Board Meeting25 Apr 202418 Apr 2024
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31 2024. Please Find Attached Audited Financial Results for Quarter and Year ended 31st March 2024 (As Per BSE Announcement Dated on 25/04/2024)

Glenmark Life: Related News

Glenmark Life Sciences’ Q2 net profit falls 20% y-o-y
25 Oct 2024|12:27 PM

The Mumbai-based company's income from operations decreased by roughly 15% to ₹507 Crore in the three months ended September 30.

Read More
Top stocks for today - 25th October 2024
25 Oct 2024|08:14 AM

Here are some of the stocks that may see significant price movement today: ITC, Kansai Nerolac, Coromandel International, etc.

Read More
Glenmark Pharmaceuticals divests stake in Glenmark Life after Nirma Acquisition
11 Jul 2024|01:16 PM

The sale will be conducted through the stock exchange mechanism, adhering to applicable legal requirements.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.